dc.contributor.author | Emadi, SS | |
dc.contributor.author | Soufi, FG | |
dc.contributor.author | Khamaneh, AM | |
dc.contributor.author | Alipour, MR | |
dc.date.accessioned | 2018-08-26T09:01:38Z | |
dc.date.available | 2018-08-26T09:01:38Z | |
dc.date.issued | 2014 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/55022 | |
dc.description.abstract | Objective. The present study was designed to evaluate whether microRNA-146a, as an NF-?B regulating factor and its adapter proteins (TRAF6 and IRAK1), are affected by diabetes in rat aorta. Methods. Male Wistar rats were randomly divided into control and diabetic groups (n=6 in each). Diabetes was induced by a single injection of streptozotocin (55 mg/kg; i.p.) in 12 h fasted rats. The gene expression of microRNA-146a, NF-?B, IRAK1, and TRAF6 were determined by real time PCR. Results. The expression of microRNA-146a was down-regulated in diabetic aorta when compared with the control group (p<0.05). The mRNA expression levels of NF-?B, TRAF6 and IRAK1 also increased in the diabetic rat aorta when compared with their control counterparts (p<0.01 for all comparisons). Conclusion. These results suggest that down-regulation of microRNA-146a may lead to derangement in NF-?B negative feedback loop, propelling the aorta toward inflammation. é 2014, Institute of Experimental Endocrinology. All rights reserved. | |
dc.language.iso | English | |
dc.relation.ispartof | Endocrine Regulations | |
dc.subject | immunoglobulin enhancer binding protein | |
dc.subject | interleukin 1 receptor associated kinase 1 | |
dc.subject | microRNA 146a | |
dc.subject | tumor necrosis factor receptor associated factor 6 | |
dc.subject | immunoglobulin enhancer binding protein | |
dc.subject | microRNA | |
dc.subject | MIRN146 microRNA, rat | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | Article | |
dc.subject | controlled study | |
dc.subject | diabetes mellitus | |
dc.subject | down regulation | |
dc.subject | male | |
dc.subject | nonhuman | |
dc.subject | protein expression | |
dc.subject | rat | |
dc.subject | real time polymerase chain reaction | |
dc.subject | signal transduction | |
dc.subject | upregulation | |
dc.subject | animal | |
dc.subject | aorta | |
dc.subject | article | |
dc.subject | experimental diabetes mellitus | |
dc.subject | gene expression | |
dc.subject | genetics | |
dc.subject | inflammation | |
dc.subject | metabolism | |
dc.subject | pathology | |
dc.subject | Wistar rat | |
dc.subject | Animals | |
dc.subject | Aorta | |
dc.subject | Diabetes Mellitus, Experimental | |
dc.subject | Gene Expression | |
dc.subject | Inflammation | |
dc.subject | Male | |
dc.subject | MicroRNAs | |
dc.subject | NF-kappa B | |
dc.subject | Rats | |
dc.subject | Rats, Wistar | |
dc.subject | Signal Transduction | |
dc.title | MicroRNA-146a expression and its intervention in NF-?B signaling pathway in diabetic rat aorta | |
dc.type | Article | |
dc.citation.volume | 48 | |
dc.citation.issue | 2 | |
dc.citation.spage | 103 | |
dc.citation.epage | 108 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.4149/endo_2014_02_103 | |